APA (7th ed.) Citation
(2026). Expression of Concern: Dietary Compound Isoliquiritigenin Inhibits Breast Cancer Neoangiogenesis via VEGF/VEGFR-2 Signaling Pathway. PLOS ONE.
Chicago Style (17th ed.) Citation
"Expression of Concern: Dietary Compound Isoliquiritigenin Inhibits Breast Cancer Neoangiogenesis via VEGF/VEGFR-2 Signaling Pathway." PLOS ONE 2026.
MLA (9th ed.) Citation
"Expression of Concern: Dietary Compound Isoliquiritigenin Inhibits Breast Cancer Neoangiogenesis via VEGF/VEGFR-2 Signaling Pathway." PLOS ONE, 2026.
Warning: These citations may not always be 100% accurate.